@article{article, title  = {{Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2022}},

 month = {{9}},

 author = {{Hardt K and Vandebosch A and Sadoff J and Le Gars M and Truyers C and Lowson D and Van Dromme I and Vingerhoets J and Kamphuis T and Scheper G and Ruiz-Guiñazú J et al}},

 doi = {{10.1016/s1473-3099(22)00506-0}},

 journal = {{The Lancet Infectious Diseases}},

 note = {{Accessed on 2024/10/18}}}